Health Minister Mark Butler was very deliberate in response to a question about the future of multiple sclerosis therapies on the PBS, and his message that these medicines should remain on the PBS was unmistakable. Are the relevant people listening?
Minister looks to be sending a very clear message about these therapies and the PBS
July 2, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy
July 2, 2026 - - Australian Biotech -
The end-game of strong-arming companies over prices at the expense of patients and process
July 2, 2026 - - Latest News -
Minister looks to be sending a very clear message about these therapies and the PBS
July 2, 2026 - - Latest News -
Commercial outsourcing emerges as a strategic option to patient access
July 1, 2026 - - Latest News -
The minister is following a tried and tested process, but what is the risk in this new world?
July 1, 2026 - - Latest News -
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 - - Latest News -
Protection gap leaves older Australians vulnerable this winter
July 1, 2026 - - Latest News


